Treatment for HIV

Phase-Based Progress Estimates
Us Helping Us, People Into Living, Inc., Washington, United States
What conditions do you have?

Study Summary

This trial will test the feasibility and acceptability of an intervention to increase PrEP initiation and adherence among black gay and bisexual men in the Washington, DC area. This treatment is used to treat HIV and there is no placebo involved in this trial.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

2 Primary · 3 Secondary · Reporting Duration: Immediately after PrEP-using SMM enroll as an Interventionist (i.e., Recruiter)

During the peer-based debriefing sessions that occurs before a Recruiter is dismissed from the open-phase pilot.
Acceptability of Intervention as measured by Weiner et al., 2017.
Comfortability of the Intervention as measured by an adaptation of Weiner et al., 2017.
Feasibility of Intervention as measured by Weiner et al., 2017.
Immediately after PrEP-using SMM enroll as an Interventionist (i.e., Recruiter)
Network members on PrEP
Recruited Network Members

Trial Safety

Safety Progress

1 of 3

Trial Design

0 Treatment Group

30 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: immediately after prep-using smm enroll as an interventionist (i.e., recruiter)
Closest Location: Us Helping Us, People Into Living, Inc. · Washington, United States
Photo of washington 1Photo of washington 2Photo of washington 3
N/AFirst Recorded Clinical Trial
0 TrialsResearching HIV
0 CompletedClinical Trials

Who is running the clinical trial?

Us Helping Us, People Into Living, Inc.Lead Sponsor
DeMarc A Hickson, PhDPrincipal InvestigatorExecutive Director

Eligibility Criteria

Age 18+ · Male Participants · 7 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You identify as a cisgender male.
You are a resident of the greater Washington, DC area.
You are HIV-negative.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.